Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 18
1986 19
1987 28
1988 22
1989 34
1990 43
1991 23
1992 15
1993 10
1994 6
1995 6
1996 6
1997 6
1998 6
1999 5
2000 1
2001 4
2002 1
2003 4
2004 2
2005 5
2006 3
2007 3
2008 3
2009 6
2010 8
2011 9
2012 11
2013 7
2014 12
2015 11
2016 21
2017 20
2018 15
2019 11
2020 15
2021 29
2022 18
2023 23
2024 48
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

521 results

Results by year

Filters applied: . Clear all
Page 1
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Carmeli Y, Cisneros JM, Paul M, Daikos GL, Wang M, Torre-Cisneros J, Singer G, Titov I, Gumenchuk I, Zhao Y, Jiménez-Rodríguez RM, Liang L, Chen G, Pyptiuk O, Aksoy F, Rogers H, Wible M, Arhin FF, Luckey A, Leaney JL, Pypstra R, Chow JW; COMBACTE-CARE consortium REVISIT study group. Carmeli Y, et al. Lancet Infect Dis. 2025 Feb;25(2):218-230. doi: 10.1016/S1473-3099(24)00499-7. Epub 2024 Oct 7. Lancet Infect Dis. 2025. PMID: 39389071 Clinical Trial.
Aztreonam.
Tunkel AR, Scheld WM. Tunkel AR, et al. Infect Control Hosp Epidemiol. 1990 Sep;11(9):486-94. doi: 10.1086/646216. Infect Control Hosp Epidemiol. 1990. PMID: 2230052 Review.
Aztreonam: clinical pharmacology.
Stutman HR. Stutman HR. Pediatr Infect Dis J. 1989 Sep;8(9 Suppl):S104-8; discussion S128-32. Pediatr Infect Dis J. 1989. PMID: 2682507 Review.
Aztreonam.
Childs SJ, Bodey GP. Childs SJ, et al. Pharmacotherapy. 1986 Jul-Aug;6(4):138-52. doi: 10.1002/j.1875-9114.1986.tb03468.x. Pharmacotherapy. 1986. PMID: 3534798 Review.
Aztreonam.
Cunha BA. Cunha BA. Urology. 1993 Mar;41(3):249-58. doi: 10.1016/0090-4295(93)90568-u. Urology. 1993. PMID: 8442309 Review.
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.
Cornely OA, Cisneros JM, Torre-Cisneros J, Rodríguez-Hernández MJ, Tallón-Aguilar L, Calbo E, Horcajada JP, Queckenberg C, Zettelmeyer U, Arenz D, Rosso-Fernández CM, Jiménez-Jorge S, Turner G, Raber S, O'Brien S, Luckey A; COMBACTE-CARE consortium/REJUVENATE Study Group. Cornely OA, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):618-627. doi: 10.1093/jac/dkz497. J Antimicrob Chemother. 2020. PMID: 31828337 Free PMC article. Clinical Trial.
521 results